| Symbol | Company | Weighting |
|---|---|---|
| GH | GUARDANT HEALTH INC | 3.01% |
| ASND | ASCENDIS PHARMA A/S DKK 1.0 ADR | 2.50% |
| PEN | PENUMBRA INC | 2.47% |
| SMMT | SUMMIT THERAPEUTICS INC. | 2.40% |
| LLY | ELI LILLY CORP | 2.22% |
| MCK | MCKESSON CORP | 2.20% |
| AXSM | AXSOME THERAPEUTICS INC. | 2.16% |
| ELV | ELEVANCE HEALTH INC | 2.14% |
| BSX | BOSTON SCIENTIFIC | 2.14% |
| ABT | ABBOTT LABORATORIES | 2.13% |
| ALC | ALCON INC | 2.11% |
| SNY | SANOFI- AVENTIS- ADR | 2.10% |
| AZN | ASTRAZENECA PLC-ADR | 2.08% |
| MOH | MOLINA HEALTHCARE INC | 2.00% |
| TVTX | TRAVERE THERAPEUTICS INC | 1.96% |
| AMLX | AMYLYX PHARMACEUTICALS INC | 1.96% |
| ISRG | INTUITIVE SURGICAL INC | 1.95% |
| ARGX | ARGENX SE ADR | 1.95% |
| MRUS | MERUS NV | 1.94% |
| BMRN | BIOMARIN PHARAMCEUTICAL INC | 1.93% |
| CI | THE CIGNA GROUP | 1.91% |
| HCA | HCA HOLDINGS INC | 1.87% |
| SYK | STRYKER CORP | 1.85% |
| DXCM | DEXCOM INC | 1.82% |
| INSM | INSMED INC | 1.82% |
| RMD | RESMED INC | 1.80% |
| BDX | BECTON DICKINSON & CO | 1.69% |
| HUM | HUMANA INC | 1.68% |
| NAMS | NEWAMSTERDAM PHARMA CO NV | 1.67% |
| ZTS | ZOETIS INC | 1.66% |
| MRK | MERCK & CO. NEW | 1.63% |
| NBIX | NEUROCRINE BIOSCIENCES INC | 1.63% |
| INSP | INSPIRE MEDICAL SYSTEMS, INC. | 1.61% |
| TMO | THERMO FISHER SCIENTIFIC INC | 1.61% |
| SNDX | SYNDAX PHARMACEUTICALS, INC. | 1.59% |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 1.57% |
| CNTA | CENTESSA PHARMACEUTI | 1.57% |
| THC | TENET HEALTHCARE CORP | 1.55% |
| CYTK | CYTOKINETICS INC | 1.54% |
| COO | COOPER COS INC | 1.54% |
| NUVL | NUVALENT INC | 1.54% |
| GEHC | GE HEALTHCARE TECHNOLOGIES INC | 1.52% |
| REGN | REGENERON PHARMACEUTICALS | 1.52% |
| ABVX | ABIVAX SA | 1.48% |
| BIIB | BIOGEN INC | 1.43% |
| IDYA | IDEAYA BIOSCIENCES, INC | 1.41% |
| ICLR | ICON PLC | 1.38% |
| ARWR | ARROWHEAD PHARMACEUTICALS INC | 1.35% |
| UNH | UNITEDHEALTH GROUP INC | 1.33% |
| RVMD | REVOLUTION MEDICINES INC | 1.31% |
| GKOS | GLAUKOS CORPORATION | 1.29% |
| TNDM | TANDEM DIABETES CARE INC | 1.15% |
| IMTX | IMMATICS NV | 1.11% |
| NVO | NOVO NORDISK A/S | 1.10% |
| IMVT | IMMUNOVANT INC | 1.08% |
| EWTX | EDGEWISE THERAPEUTICS | 0.89% |
| ARVN | ARVINAS INC USD | 0.76% |
| PCVX | VAXCYTE INC | 0.73% |
| GERN | GERON CORP | 0.68% |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, GS GAMMA Advisors, LLC, and Guggenheim Private Investments, LLC. Securities offered through Guggenheim Funds Distributors, LLC.
© 2025 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.